SCFFbxw7/hCdc4 targets cyclin E2 for ubiquitin-dependent proteolysis

Experimental Cell Research

Volumn 315, Issue 11, 2009, Pages 1832-1839

  Klotz, Kathleen ^a   Cepeda, Diana ^b   Tan, YingMeei ^a   Sun, Dahui ^a   Sangfelt, Olle ^b   Spruck, Charles ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cyclin E2; Fbw7; Fbxw7; hCdc4, SCF; Ubiquitin

Indexed keywords

CYCLIN E; CYCLIN E2; SERINE; THREONINE; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; UBIQUITIN PROTEIN LIGASE SCF; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; UBIQUITINATION;

MAMMALIA;

EID: 67349114221     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.11.017     Document Type: Article

References (34)

1. Reed S.I. Ratchets and clocks: the cell cycle, ubiquitylation and protein turnover. Nat. Rev. Mol. Cell Biol. 4 (2003) 855-864
2. Ekholm S.V., and Reed S.I. Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12 (2000) 676-684
3. Geng Y., Yu Q., Sicinska E., Das M., Scheider J.E., Bhattacharya S., Rideout W.M., Bronson R.T., Gardner H., and Sicinski P. Cyclin E alblation in the mouse. Cell 114 (2003) 431-443
4. Moroy T., and Geisen C. Cyclin E. Int. J. Biochem. Cell Biol. 36 (2004) 1424-1439
5. Gudas J.M., Payton M., Thukral S., Chen E., Bass M., and Robinson M.O. Cyclin E2, a novel G1 cyclin that binds Cdk2 and is aberrantly expressed in human cancers. Mol. Cell. Biol. 19 (1999) 612-622
6. Zariwala M., Liu J., and Xiong Y. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 17 (1998) 2787-2798
7. Lauper N., Beck A.R., Cariou S., Richman L., Hofmann K., Reith W., Slingerland J.M., and Amati B. Cyclin E2: a novel CDK2 partner in the late G1 and S phases of the mammalian cells cycle. Oncogene 17 (1998) 2637-2643
8. Geng Y., Yu Q., Whoriskey W., Dick F., Tsai K.Y., Ford H.L., Biswas D.K., Pardee A.B., Amati B., Jacks T., Richardson A., Dyson N., and Sicinski P. Expression of cyclins E1 and E2 during mouse development and in neoplasia. Proc. Natl. Acad. Sci. 98 (2001) 13138-13143
9. Resnitzky D., Gossen M., Bujard H., and Reed S.I. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14 (1994) 1669-1679
10. Parisi T., Beck A.R., Rougier N., McNeil T., Lucian L., Werb Z., and Amati B. Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells. EMBO J. 22 (2003) 4794-4803
11. Gotoh T., Shigemoto N., and Kishimoto T. Cyclin E2 is required for embryogenesis in Xenopus laevis. Dev. Biol. 310 (2007) 341-347
12. Ishii H., Mimori K., Yoshikawa Y., Mori M., Furukawa Y., and Vecchione A. Differential roles of E-type cyclins during transformation of murine E2F-1-decificent cells. DNA Cell Biol. 24 (2005) 173-179
13. Keyomarsi K., Tucker S.L., Buchholz T.A., Callister M., Ding Y., Hortobagyi G.N., Bedrosian I., Knickerbocker C., Toyofuku W., Lowe M., Herliczek T.W., and Bacus S.S. Cyclin E and survival in patients with breast cancer. N. Engl. J. Med. 347 (2002) 1566-1575
14. Payton M., Scully S., Chung G., and Coats S. Deregulation of cyclin E2 expression and associated kinase activity in primary breast tumors. Oncogene 21 (2002) 8529-8534
15. Sieuwerts A.M., Look M.P., Meijer-van Gelder M.E., Timmermans M., Trapman A.M., Garcia R.R., Arnold M., Goedheer A.J., de Weerd V., Portengen H., Klijn J.G., and Foekens J.A. Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients. Clin. Cancer Res. 12 (2006) 3319-3328
16. Spruck C.H., Won K.A., and Reed S.I. Deregulated cyclin E induces chromosome instability. Nature 401 (1999) 297-300
17. Bortner D.M., and Rosenberg M.P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell Biol. 17 (1997) 453-459
18. Strohmaier H., Spruck C.H., Kaiser P., Won K.A., Sangfelt O., and Reed S.I. Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 413 (2001) 316-322
19. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. Archipeligo regulates cyclin E levels in drosophila and is mutated in human cancer cell lines. Nature 413: 311-316.
20. Koepp D.M., Schaefer L.K., Ye X., Keyomarsi K., Chu C., Harper J.W., and Elledge S.J. Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science 294 (2001) 173-177
21. Ekholm-Reed S., Spruck C.H., Sangfelt O., van Drogen F., Muller-Holzner E., Widschwendter M., Zetterberg A., and Reed S.I. Mutation of hCDC4 leads to cell cycle deregulation of cyclin E in cancer. Cancer Res. 64 (2004) 795-800
22. Rajagopalan H., Jallepalli P.V., Rago C., Velculescu V.E., Kinzler K.W., Vogelstein B., and Lengauer C. Inactivation of hCDC4 can cause chromosomal instability. Nature 428 (2004) 77-81
23. Keck J.M., Summers M.K., Tedesco D., Ekholm-Reed S., Chuang L.C., Jackson P.K., and Reed S.I. Cyclin E overexpression impairs progression through mitosis by inhibiting ACP(Cdh1). J. Cell Biol. 178 (2007) 371-385
24. Won K.A., and Reed S.I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15 (1996) 4182-4193
25. Clurman B.E., Sheaff R.j., Thress K., Groudine M., and Roberts J.M. Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev. 10 (1996) 1979-1990
26. Welker M., and Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 8 (2008) 83-93
27. Orlicky S., Tang X., Willems A., Tyers M., and Sicheri F. Structural basis for phosphodependent substrate selection and orientation by the SCFCdc4 ubiquitin ligase. Cell 112 (2003) 243-256
28. Ye X., Nalepa G., Welker M., Kessler B.M., Spooner E., Qin J., Elledge S.J., Clurman B.E., and Harper J.W. Recognition of phosphodegron motifs in human cyclin E by SCF(Fbw7) ubiquitin ligase. J. Biol. Chem. 279 (2004) 50110-50119
29. Hao B., Oehlmann S., Sowa M.E., Harper J.W., and Pavletich N.P. Structure of a Fbw7-Skp1-cyclin E complex: multisite-phosphorylated substrate recognition by SCF ubiquitin ligases. Mol. Cell. 26 (2007) 131-143
30. Welker M., Singer J., Loeb K.R., Grim J., Bloecher A., Gurien-West M., Clurman B.E., and Roberts J.M. Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. Mol. Cell. 12 (2003) 381-392
31. Knuutila S., Aalto Y., Autio K., Bjorkqvist A.M., El-Rifai W., Hemmer S., Huhta T., Kettunen E., Kiuru-Kuhlefelt S., Larramendy M.L., Lushnikova T., Monni O., Pere H., Tapper J., Tarkkanen M., Varis A., Wasenius V.M., Wolf M., and Zhu Y. DNA copy number losses in human neoplasms. Am. J. Path. 155 (1999) 683-694
32. Mao J.H., Perez-Losada J., Wu D., Delrosario R., Tsunematsu R., Nakayama K.I., Brown K., Bryson S., and Balmain A. Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene. Nature 432 (2004) 775-779
33. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., Cepeda D., Fiegl H., Dafou D., Marth C., Mueller-Holzner E., Corcoran M., Dagnell M., Nejad S.Z., Nayer B.N., Zali M.R., Hansson J., Egyhazi S., Petersson F., Sangfelt P., Nordgren H., Grander D., Reed S.I., Widschwendter M., Sangfelt O., and Spruck C. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res. 67 (2007) 9006-90012
34. Spruck C.H., Sun D., Fiegl H., Marth C., Mueller-Holzner E., Goebel G., Widschwendter M., and Reed S.I. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer. Cancer Res. 66 (2006) 7355-7360